vs
HEALTHEQUITY, INC.（HQY）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
HEALTHEQUITY, INC.的季度营收约是REPLIGEN CORP的1.6倍（$322.2M vs $197.9M），HEALTHEQUITY, INC.净利率更高（16.0% vs 6.7%，领先9.3%），REPLIGEN CORP同比增速更快（13.6% vs 7.2%），HEALTHEQUITY, INC.自由现金流更多（$137.8M vs $17.6M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 10.8%）
HealthEquity, Inc.是美国一家金融科技及商业服务企业，拥有美国国税局授予的非银行类健康储蓄受托人资质，无论用户资金存入哪家金融机构，该公司均可作为对应健康储蓄账户的托管方，提供专业账户管理服务。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
HQY vs RGEN — 直观对比
营收规模更大
HQY
是对方的1.6倍
$197.9M
营收增速更快
RGEN
高出6.4%
7.2%
净利率更高
HQY
高出9.3%
6.7%
自由现金流更多
HQY
多$120.2M
$17.6M
两年增速更快
RGEN
近两年复合增速
10.8%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $322.2M | $197.9M |
| 净利润 | $51.7M | $13.3M |
| 毛利率 | 70.8% | 52.5% |
| 营业利润率 | 24.4% | 9.0% |
| 净利率 | 16.0% | 6.7% |
| 营收同比 | 7.2% | 13.6% |
| 净利润同比 | 806.4% | 143.9% |
| 每股收益（稀释后） | $0.59 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HQYRGEN
| Q4 25 | $322.2M | $197.9M | ||
| Q3 25 | $325.8M | $188.8M | ||
| Q2 25 | $330.8M | $182.4M | ||
| Q1 25 | $311.8M | $169.2M | ||
| Q4 24 | $300.4M | $174.1M | ||
| Q3 24 | $299.9M | $154.9M | ||
| Q2 24 | $287.6M | $154.1M | ||
| Q1 24 | $262.4M | $151.3M |
净利润HQYRGEN
| Q4 25 | $51.7M | $13.3M | ||
| Q3 25 | $59.9M | $14.9M | ||
| Q2 25 | $53.9M | $14.9M | ||
| Q1 25 | $26.4M | $5.8M | ||
| Q4 24 | $5.7M | $-30.3M | ||
| Q3 24 | $35.8M | $-654.0K | ||
| Q2 24 | $28.8M | $3.3M | ||
| Q1 24 | $26.4M | $2.1M |
毛利率HQYRGEN
| Q4 25 | 70.8% | 52.5% | ||
| Q3 25 | 71.4% | 53.2% | ||
| Q2 25 | 67.8% | 50.0% | ||
| Q1 25 | 60.6% | 53.6% | ||
| Q4 24 | 65.6% | 26.1% | ||
| Q3 24 | 68.0% | 50.0% | ||
| Q2 24 | 65.1% | 49.8% | ||
| Q1 24 | 63.1% | 49.5% |
营业利润率HQYRGEN
| Q4 25 | 24.4% | 9.0% | ||
| Q3 25 | 27.5% | 8.9% | ||
| Q2 25 | 25.1% | 7.6% | ||
| Q1 25 | 13.5% | 3.9% | ||
| Q4 24 | 6.5% | -17.7% | ||
| Q3 24 | 19.6% | -5.1% | ||
| Q2 24 | 14.5% | 1.0% | ||
| Q1 24 | 14.8% | 1.3% |
净利率HQYRGEN
| Q4 25 | 16.0% | 6.7% | ||
| Q3 25 | 18.4% | 7.9% | ||
| Q2 25 | 16.3% | 8.2% | ||
| Q1 25 | 8.5% | 3.4% | ||
| Q4 24 | 1.9% | -17.4% | ||
| Q3 24 | 11.9% | -0.4% | ||
| Q2 24 | 10.0% | 2.2% | ||
| Q1 24 | 10.0% | 1.4% |
每股收益（稀释后）HQYRGEN
| Q4 25 | $0.59 | $0.24 | ||
| Q3 25 | $0.68 | $0.26 | ||
| Q2 25 | $0.61 | $0.26 | ||
| Q1 25 | $0.30 | $0.10 | ||
| Q4 24 | $0.06 | $-0.55 | ||
| Q3 24 | $0.40 | $-0.01 | ||
| Q2 24 | $0.33 | $0.06 | ||
| Q1 24 | $0.30 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $309.3M | $767.6M |
| 总债务越低越好 | $982.1M | $542.2M |
| 股东权益账面价值 | $2.1B | $2.1B |
| 总资产 | $3.4B | $2.9B |
| 负债/权益比越低杠杆越低 | 0.46× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资HQYRGEN
| Q4 25 | $309.3M | $767.6M | ||
| Q3 25 | $304.5M | $748.7M | ||
| Q2 25 | $287.9M | $708.9M | ||
| Q1 25 | $295.9M | $697.2M | ||
| Q4 24 | $322.2M | $757.4M | ||
| Q3 24 | $326.9M | $784.0M | ||
| Q2 24 | $251.2M | $809.1M | ||
| Q1 24 | $404.0M | $780.6M |
总债务HQYRGEN
| Q4 25 | $982.1M | $542.2M | ||
| Q3 25 | $1.0B | $537.9M | ||
| Q2 25 | $1.1B | — | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | $1.1B | $525.6M | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $925.7M | — | ||
| Q1 24 | $875.0M | — |
股东权益HQYRGEN
| Q4 25 | $2.1B | $2.1B | ||
| Q3 25 | $2.1B | $2.1B | ||
| Q2 25 | $2.1B | $2.1B | ||
| Q1 25 | $2.1B | $2.0B | ||
| Q4 24 | $2.1B | $2.0B | ||
| Q3 24 | $2.2B | $2.0B | ||
| Q2 24 | $2.1B | $2.0B | ||
| Q1 24 | $2.0B | $2.0B |
总资产HQYRGEN
| Q4 25 | $3.4B | $2.9B | ||
| Q3 25 | $3.4B | $2.9B | ||
| Q2 25 | $3.4B | $2.9B | ||
| Q1 25 | $3.4B | $2.9B | ||
| Q4 24 | $3.5B | $2.8B | ||
| Q3 24 | $3.5B | $2.8B | ||
| Q2 24 | $3.2B | $2.9B | ||
| Q1 24 | $3.2B | $2.8B |
负债/权益比HQYRGEN
| Q4 25 | 0.46× | 0.26× | ||
| Q3 25 | 0.47× | 0.26× | ||
| Q2 25 | 0.50× | — | ||
| Q1 25 | 0.50× | — | ||
| Q4 24 | 0.51× | 0.27× | ||
| Q3 24 | 0.51× | — | ||
| Q2 24 | 0.44× | — | ||
| Q1 24 | 0.43× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $138.6M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $137.8M | $17.6M |
| 自由现金流率自由现金流/营收 | 42.8% | 8.9% |
| 资本支出强度资本支出/营收 | 0.2% | 4.1% |
| 现金转化率经营现金流/净利润 | 2.68× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $413.0M | $93.9M |
8季度趋势，按日历期对齐
经营现金流HQYRGEN
| Q4 25 | $138.6M | $25.7M | ||
| Q3 25 | $135.9M | $48.1M | ||
| Q2 25 | $64.7M | $28.6M | ||
| Q1 25 | $75.7M | $15.0M | ||
| Q4 24 | $90.5M | $39.2M | ||
| Q3 24 | $108.1M | $49.3M | ||
| Q2 24 | $65.4M | $42.2M | ||
| Q1 24 | $77.1M | $44.7M |
自由现金流HQYRGEN
| Q4 25 | $137.8M | $17.6M | ||
| Q3 25 | $135.1M | $43.4M | ||
| Q2 25 | $64.7M | $21.5M | ||
| Q1 25 | $75.4M | $11.4M | ||
| Q4 24 | $90.3M | $33.6M | ||
| Q3 24 | $107.4M | $42.3M | ||
| Q2 24 | $64.7M | $37.4M | ||
| Q1 24 | $76.5M | $36.4M |
自由现金流率HQYRGEN
| Q4 25 | 42.8% | 8.9% | ||
| Q3 25 | 41.5% | 23.0% | ||
| Q2 25 | 19.5% | 11.8% | ||
| Q1 25 | 24.2% | 6.8% | ||
| Q4 24 | 30.0% | 19.3% | ||
| Q3 24 | 35.8% | 27.3% | ||
| Q2 24 | 22.5% | 24.3% | ||
| Q1 24 | 29.2% | 24.0% |
资本支出强度HQYRGEN
| Q4 25 | 0.2% | 4.1% | ||
| Q3 25 | 0.2% | 2.5% | ||
| Q2 25 | 0.0% | 3.9% | ||
| Q1 25 | 0.1% | 2.1% | ||
| Q4 24 | 0.1% | 3.2% | ||
| Q3 24 | 0.2% | 4.5% | ||
| Q2 24 | 0.3% | 3.1% | ||
| Q1 24 | 0.2% | 5.5% |
现金转化率HQYRGEN
| Q4 25 | 2.68× | 1.93× | ||
| Q3 25 | 2.27× | 3.23× | ||
| Q2 25 | 1.20× | 1.92× | ||
| Q1 25 | 2.87× | 2.57× | ||
| Q4 24 | 15.88× | — | ||
| Q3 24 | 3.02× | — | ||
| Q2 24 | 2.27× | 12.70× | ||
| Q1 24 | 2.92× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HQY
| Financial Service Other | $159.1M | 49% |
| Services | $120.3M | 37% |
| Credit And Debit Card | $42.8M | 13% |
RGEN
暂无分部数据
